AMIA responded to the FDA's draft guidance on "Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations." We commended the FDA for its comprehensive approach to ensuring the safe and effective use of AI-enabled devices in healthcare. The comment letter emphasized the importance of transparency, bias control, and […]
AMIA responded to the House Committee on Energy and Commerce's Request for Information (RFI) on data privacy and security framework. The comment letter emphasized the need for a comprehensive data privacy and security law that includes clear definitions of personal and sensitive personal information. AMIA advocated for transparency in data […]
Read the lastest issue featuring a student spotlight on 2024 Martin Epstein Award First Place Winner Victor Borza-Martin Epstein.
AMIA joined the Disability & Rehabilitation Research Coalition (DRRC), comprising 28 national organizations, commended the National Institutes of Health (NIH) for its draft Strategic Plan for Disability Health Research for FY26-FY30. The DRRC emphasized the critical need for biomedical, functional, and outcomes research to support the approximately 70 million adults […]
AMIA submitted recommendations for the U.S. AI Action Plan, emphasizing the importance of integrating AI responsibly within healthcare. Key principles include ensuring transparency about AI tools' purposes and data usage, establishing rigorous validation and continuous monitoring to maintain safety and effectiveness, reducing administrative burdens on providers through AI applications, and […]